152 related articles for article (PubMed ID: 27022262)
1. Targeting melanoma with immunoliposomes coupled to anti-MAGE A1 TCR-like single-chain antibody.
Saeed M; van Brakel M; Zalba S; Schooten E; Rens JA; Koning GA; Debets R; Ten Hagen TL
Int J Nanomedicine; 2016; 11():955-75. PubMed ID: 27022262
[TBL] [Abstract][Full Text] [Related]
2. Chimeric antigen receptors with human scFvs preferentially induce T cell anti-tumor activity against tumors with high B7H6 expression.
Gacerez AT; Hua CK; Ackerman ME; Sentman CL
Cancer Immunol Immunother; 2018 May; 67(5):749-759. PubMed ID: 29453518
[TBL] [Abstract][Full Text] [Related]
3. Preclinical evaluation of a novel CAR-T therapy utilizing a scFv antibody highly specific to MAGE-A4
Wang L; Matsumoto M; Akahori Y; Seo N; Shirakura K; Kato T; Katsumoto Y; Miyahara Y; Shiku H
Mol Ther; 2024 Mar; 32(3):734-748. PubMed ID: 38243600
[TBL] [Abstract][Full Text] [Related]
4. Generation of a stable anti-human CD44v6 scFv and analysis of its cancer-targeting ability in vitro.
Chen Y; Huang K; Li X; Lin X; Zhu Z; Wu Y
Cancer Immunol Immunother; 2010 Jun; 59(6):933-42. PubMed ID: 20224978
[TBL] [Abstract][Full Text] [Related]
5. The use of single chain Fv as targeting agents for immunoliposomes: an update on immunoliposomal drugs for cancer treatment.
Cheng WW; Allen TM
Expert Opin Drug Deliv; 2010 Apr; 7(4):461-78. PubMed ID: 20331354
[TBL] [Abstract][Full Text] [Related]
6. The physiological interactome of TCR-like antibody therapeutics in human tissues.
Marrer-Berger E; Nicastri A; Augustin A; Kramar V; Liao H; Hanisch LJ; Carpy A; Weinzierl T; Durr E; Schaub N; Nudischer R; Ortiz-Franyuti D; Breous-Nystrom E; Stucki J; Hobi N; Raggi G; Cabon L; Lezan E; Umaña P; Woodhouse I; Bujotzek A; Klein C; Ternette N
Nat Commun; 2024 Apr; 15(1):3271. PubMed ID: 38627373
[TBL] [Abstract][Full Text] [Related]
7. An Engineered M13 Filamentous Nanoparticle as an Antigen Carrier for a Malignant Melanoma Immunotherapeutic Strategy.
Brišar N; Šuster K; Brezar SK; Vidmar R; Fonović M; Cör A
Viruses; 2024 Feb; 16(2):. PubMed ID: 38400008
[TBL] [Abstract][Full Text] [Related]
8. Chimeric antigen receptor T cells secreting anti-PD-L1 antibodies more effectively regress renal cell carcinoma in a humanized mouse model.
Suarez ER; Chang de K; Sun J; Sui J; Freeman GJ; Signoretti S; Zhu Q; Marasco WA
Oncotarget; 2016 Jun; 7(23):34341-55. PubMed ID: 27145284
[TBL] [Abstract][Full Text] [Related]
9. An optimized single chain TCR scaffold relying on the assembly with the native CD3-complex prevents residual mispairing with endogenous TCRs in human T-cells.
Knies D; Klobuch S; Xue SA; Birtel M; Echchannaoui H; Yildiz O; Omokoko T; Guillaume P; Romero P; Stauss H; Sahin U; Herr W; Theobald M; Thomas S; Voss RH
Oncotarget; 2016 Apr; 7(16):21199-221. PubMed ID: 27028870
[TBL] [Abstract][Full Text] [Related]
10. Opportunities and challenges for TCR mimic antibodies in cancer therapy.
Chang AY; Gejman RS; Brea EJ; Oh CY; Mathias MD; Pankov D; Casey E; Dao T; Scheinberg DA
Expert Opin Biol Ther; 2016 Aug; 16(8):979-87. PubMed ID: 27094818
[TBL] [Abstract][Full Text] [Related]
11. TCR-like antibody drug conjugates mediate killing of tumor cells with low peptide/HLA targets.
Lowe DB; Bivens CK; Mobley AS; Herrera CE; McCormick AL; Wichner T; Sabnani MK; Wood LM; Weidanz JA
MAbs; 2017; 9(4):603-614. PubMed ID: 28273004
[TBL] [Abstract][Full Text] [Related]
12. IGF2BP2 promotes colorectal cancer cell proliferation and survival through interfering with RAF-1 degradation by miR-195.
Ye S; Song W; Xu X; Zhao X; Yang L
FEBS Lett; 2016 Jun; 590(11):1641-50. PubMed ID: 27153315
[TBL] [Abstract][Full Text] [Related]
13. Target Density, Not Affinity or Avidity of Antigen Recognition, Determines Adoptive T Cell Therapy Outcomes in a Mouse Lymphoma Model.
Segal G; Prato S; Zehn D; Mintern JD; Villadangos JA
J Immunol; 2016 May; 196(9):3935-42. PubMed ID: 27036915
[TBL] [Abstract][Full Text] [Related]
14. A transplant "immunome" screening platform defines a targetable epitope fingerprint of multiple myeloma.
Schieferdecker A; Oberle A; Thiele B; Hofmann F; Göthel M; Miethe S; Hust M; Braig F; Voigt M; von Pein UM; Koch-Nolte F; Haag F; Alawi M; Indenbirken D; Grundhoff A; Bokemeyer C; Bacher U; Kröger N; Binder M
Blood; 2016 Jun; 127(25):3202-14. PubMed ID: 27034429
[TBL] [Abstract][Full Text] [Related]
15. Targeting Epstein-Barr virus-transformed B lymphoblastoid cells using antibodies with T-cell receptor-like specificities.
Lai J; Tan WJ; Too CT; Choo JA; Wong LH; Mustafa FB; Srinivasan N; Lim AP; Zhong Y; Gascoigne NR; Hanson BJ; Chan SH; Chen J; MacAry PA
Blood; 2016 Sep; 128(10):1396-407. PubMed ID: 27338099
[TBL] [Abstract][Full Text] [Related]
16. MAGE-A is More Highly Expressed Than NY-ESO-1 in a Systematic Immunohistochemical Analysis of 3668 Cases.
Kerkar SP; Wang ZF; Lasota J; Park T; Patel K; Groh E; Rosenberg SA; Miettinen MM
J Immunother; 2016 May; 39(4):181-7. PubMed ID: 27070449
[TBL] [Abstract][Full Text] [Related]
17. Reprogramming of Melanoma Tumor-Infiltrating Lymphocytes to Induced Pluripotent Stem Cells.
Saito H; Okita K; Fusaki N; Sabel MS; Chang AE; Ito F
Stem Cells Int; 2016; 2016():8394960. PubMed ID: 27057178
[TBL] [Abstract][Full Text] [Related]
18. Liposomes targeted to MHC-restricted antigen improve drug delivery and antimelanoma response.
Saeed M; Zalba S; Seynhaeve ALB; Debets R; Ten Hagen TLM
Int J Nanomedicine; 2019; 14():2069-2089. PubMed ID: 30988609
[TBL] [Abstract][Full Text] [Related]
19. T Cells Expressing a TCR-Like Antibody Selected Against the Heteroclitic Variant of a Shared MAGE-A Epitope Do Not Recognise the Cognate Epitope.
Saeed M; Schooten E; van Brakel M; Cole DK; Ten Hagen TLM; Debets R
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32429338
[TBL] [Abstract][Full Text] [Related]
20. Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response.
Chen G; Huang AC; Zhang W; Zhang G; Wu M; Xu W; Yu Z; Yang J; Wang B; Sun H; Xia H; Man Q; Zhong W; Antelo LF; Wu B; Xiong X; Liu X; Guan L; Li T; Liu S; Yang R; Lu Y; Dong L; McGettigan S; Somasundaram R; Radhakrishnan R; Mills G; Lu Y; Kim J; Chen YH; Dong H; Zhao Y; Karakousis GC; Mitchell TC; Schuchter LM; Herlyn M; Wherry EJ; Xu X; Guo W
Nature; 2018 Aug; 560(7718):382-386. PubMed ID: 30089911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
